Mexidol® for arterial hypertension (AG). AH and cognitive disorders, effective correction methods

Time codes:
  • 00:00

    Arterial hypertension and its effect on the brain, Mexidol® with hypertension

  • 00:20

    Signs of brain damage to arterial hypertension

  • 01:07

    Correction of risk factors to improve cognitive functions

  • 02:16

    The role of the drug Mexidol® for cognitive impairment

Ostroumova Olga Dmitrievna – Doctor of Medical Sciences, Professor, Head. Department of Therapy and Polymorbid Pathology named after. Academician M.S. Vovsi FSBEI DPO RMANPE Ministry of Health of Russia

Announcement:

Increased blood pressure is the main factor of high risk of premature death, brain stroke, myocardial infarction and other cardiovascular complications.

The most vulnerable blending organ with arterial hypertension is the brain.

The clinical manifestation of brain damage, the target organ of hypertension, is cognitive impairment, such as memory and attention deficits. Thus, cognitive impairment is caused by hypertension. To optimize antihypertensive therapy, in addition to standard medications, it is necessary to include neurometabolic agents, preferably those that deliver multiple effects in a single tablet. Mexidol® is such a drug.It has a membrane-stabilizing and antioxidant effect and improves cerebral perfusion, which is extremely important in hypertension. Proper standard therapy and the right adjunctive medication with a multimodal mechanism of action ensure maximum improvement in cognitive function and, consequently, in patients' quality of life.

Block of articles on this topic

Personal: International multicenter randomized double-tied placebo-controlled study of evaluating the effectiveness and safety of sequential therapy of patients with chronic brain ischemia drugs Mexidol® and Mexidol® Forte 250: Subanalysis results in patients with arterial hypertension

Authors:
V.V. ZAKHAROV1, O.D. OSTROUMOVA1,2, A.I. KOCHETKOV2, M.V. KLEPIKOVA2, A.I. FEDIN3

Personal: Resolution of the Council of Experts “The possibilities of neuroprotective therapy in patients with arterial hypertension and cognitive disorders”
The possibilities of multimodal neuroprotection in patients with chronic brain ischemia against the background of arterial hypertension and atherosclerosis

Authors:
I.A. GRIBACHEV, T.F. POPOVA, E.V. PETROVA, A.V. ZVONKOVA

FSBEI in Novosibirsk State Medical University of the Ministry of Health of Russia

Cognitive disorders in the practice of a primary link: Focus for patients with arterial hypertension

Authors:
O.D. OSTROUMOVA, A.I. KOCHETKOV, N.A. SHATALOVA

Cognitive disorders of vascular genesis in the practice of the therapist

Author:
P.R. KAMCHATNOV1, R.A. CHEREMIN2, L.A. SKIPETROVA2, A.V. CHUGUNOV1

1Federal State Autonomous Educational Institution of Higher Education “N.I. Pirogov Russian National Medical University” of the Ministry of Health of the Russian Federation, Moscow
2State Budgetary Healthcare Institution “Center for Speech Pathology and Neurorehabilitation of the Moscow Department of Health”

THE INFORMATION IS INTENDED FOR HEALTHCARE AND PHARMACEUTICAL PROFESSIONALS. THIS INFORMATION IS NOT INTENDED AS A SUBSTITUTE FOR MEDICAL ADVICE.

Source of photos and images Shutterstock.com